|
Cannabis extracts (drops, capsules)
|
|---|
| |
Total
|
Hybrid
|
Indica
|
Sativa
|
3:1 CBD:THC
|
1:1 CBD:THC
|
|---|
|
Headache as primary symptom (505)
|
195 (38.6%)
|
36 (18.5%)
|
51 (26.2%)
|
15 (7.7%)
|
53 (27.2%)
|
40 (20.5%)
|
|
Headache as primary illness (75)
|
26 (34.7%)
|
7 (26.9%)
|
5 (19.2%)
|
1 (3.9%)
|
9 (34.6%)
|
4 (15.4%)
|
|
Chronic pain as primary illness (598)
|
248 (41.5%)
|
44 (17.7%)
|
56 (22.6%)
|
18 (7.3%)
|
60 (24.2%)
|
66 (26.6%)
|
|
Arthritis as primary illness (188)
|
80 (42.6%)
|
14 (17.5%)
|
11 (13.8%)
|
5 (6.3%)
|
26 (32.5%)
|
24 (30%)
|
|
3 Yes (343)a
|
143 (41.7%)
|
25 (17.5%)
|
41 (28.7%)
|
6 (4.2%)
|
39 (27.3%)
|
32 (22.4%)
|
|
2 Yes (102)b
|
33 (32.4%)
|
6 (18.2%)
|
7 (21.2%)
|
5 (15.2%)
|
9 (27.3%)
|
6 (18.2%)
|
|
3 + 2 Yes (445)
|
176 (39.6%)
|
31 (17.6%)
|
48 (27.3%)
|
11 (6.3%)
|
48 (27.3%)
|
38 (21.6%)
|
- a3 “Yes” responses = 97% probability of migraine
- b2 “Yes” responses = 93% probability of migraine
